Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Dec 1997, 3026-3031, Vol 35, No. 12
HP Endtz, N van den Braak, A van Belkum, JA Kluytmans, JG Koeleman, L Spanjaard, A Voss, AJ Weersink, CM Vandenbroucke-Grauls, AG Buiting, A van Duin and HA Verbrugh
In order to determine the prevalence of vancomycin-resistant enterococci
(VRE) in The Netherlands, 624 hospitalized patients from intensive care
units or hemato-oncology wards in nine hospitals and 200 patients living in
the community were screened for VRE colonization. Enterococci were found in
49% of the hospitalized patients and in 80% of the patients living in the
community. Of these strains, 43 and 32%, respectively, were Enterococcus
faecium. VRE were isolated from 12 of 624 (2%) and 4 of 200 (2%)
hospitalized patients and patients living in the community, respectively.
PCR analysis of these 16 strains and 11 additional clinical VRE isolates
from one of the participating hospitals revealed 24 vanA gene-containing, 1
vanB gene-containing, and 2 vanC1 gene-containing strains. All strains were
cross-resistant to avoparcin but were sensitive to the novel glycopeptide
antibiotic LY333328. Genotyping of the strains by arbitrarily primed PCR
and pulsed-field gel electrophoresis revealed a high degree of genetic
heterogeneity. This underscores a lack of hospital-driven endemicity of VRE
clones. It is suggested that the VRE in hospitalized patients have
originated from unknown sources in the community.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands [In Process Citation]
Erasmus University Medical Center, Rotterdam, The Netherlands.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»